Lv43
456 积分 2024-01-19 加入
Leptomeningeal metastases: a RANO proposal for response criteria
21小时前
已完结
1846MO Intracranial efficacy of olomorasib, a second-generation KRAS G12C inhibitor, in patients with KRAS G12C-mutant NSCLC who have active, untreated brain metastases
4天前
已完结
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC
4天前
已完结
Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
4天前
已完结
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC
6天前
已完结
Furmonertinib combined with bevacizumab in EGFR-TKI-resistant leptomeningeal metastasis: analysis of the CSF ctDNA molecular response and survival outcomes
28天前
已完结
非小细胞肺癌脑膜转移的临床特征及脑脊液分子特征的临床研究
28天前
已完结
全脑低剂量放疗联合ICI及鞘内化疗治疗非小细胞肺癌脑膜转移的安全性与疗效分析
1个月前
已完结
皖公网安备34019202002308
